Sergio Bracarda European Urology Supplements

Slides:

Advertisements

Similar presentations

Pascal Rischmann European Urology Supplements

Advertisements

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Fred Saad European Urology Supplements

Prostate Cancer 2008: Challenges in Diagnosis and Management

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Renal Cell Carcinoma: Prognostic Factors and Patient Selection

Olivier Traxer European Urology Supplements

Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.

Shanthi Marur, MD, Arlene A. Forastiere, MD Mayo Clinic Proceedings

The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy Olaf A. Brinkmann,

Bladder Cancer: Management and Future Directions

Volume 50, Issue 5, Pages (November 2006)

Martin C. Michel European Urology Supplements

Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Bladder Cancer: A Major Public Health Issue

Back to the Future: Introduction and Conclusions

Volume 52, Issue 5, Pages (November 2007)

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

A Novel Treatment of Premature Ejaculation

Volume 60, Issue 5, Pages (November 2011)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Molecular Tumour Profiling for Detection of Biomarkers in Renal Cell Tumours Kerstin Junker, Jimsgene Sanjmyatav, Joerg Mueller, Thomas Steiner, Heiko.

Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy Kerstin Junker, Sebastian Hölters,

Volume 74, Issue 3, Pages (September 2018)

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

An Update of Current Practice in Hypospadias Surgery

Volume 59, Issue 1, Pages (January 2011)

Richard C. Harkaway European Urology Supplements

Volume 56, Issue 5, Pages (November 2009)

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma Sergio Bracarda, Alain Ravaud, Marino.

Tim Schneider European Urology Supplements

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

The Importance of Testosterone Control in Prostate Cancer

Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Neal Shore European Urology Supplements

Kidney Cancer: Highlights from 2006

The Hallmarks of BPH Progression and Risk Factors

Challenges and Opportunities in Hormone-Resistant Prostate Cancer

Christian Stief European Urology Supplements

Bisphosphonates Can Prevent Skeletal Complications of Malignant Bone Disease from Prostate Cancer and Renal Cell Carcinoma Fred Saad European Urology.

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Who Forms Stones and Why?

Prostate Cancer 2008: Challenges in Diagnosis and Management

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

Profile of Silodosin European Urology Supplements

New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men

European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why? Jean-Jacques Patard

Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Beyond Skeletal-Related Events

Treatment Options in Prostate Cancer Once Primary Therapy Fails

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Joaquim Bellmunt European Urology Supplements

Classification of Mixed Incontinence

The Impact of Premature Ejaculation on Partners and Relationships

Diagnosis and Management of Cryptorchidism

Epidemiology and Demographics of Prostatitis

New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer Noel W. Clarke European Urology Supplements

Jan Roigas European Urology Supplements

Pathology and Molecular Pathogenesis of Renal Cell Carcinoma

Volume 163, Issue 4, (November 2015)

Michael Marberger European Urology Supplements

Presentation transcript:

Metastatic Renal Cell Carcinoma: Pathogenesis and the Current Medical Landscape Sergio Bracarda European Urology Supplements Volume 8, Issue 10, Pages 787-792 (November 2009) DOI: 10.1016/j.eursup.2009.07.007 Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 1 Renal cell carcinoma (RCC) mortality rates per 100000 people in the United States. Patients diagnosed with a first, primary RCC during 1973–2002 were included. Adapted from Chow et al [8], based on data from the nine Surveillance, Epidemiology, and End Results registries. European Urology Supplements 2009 8, 787-792DOI: (10.1016/j.eursup.2009.07.007) Copyright © 2009 European Association of Urology Terms and Conditions